FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Norgestimate and Ethinyl Estradiol
Status: Discontinuation
»Therapeutic Categories: Reproductive

Janssen Pharmaceuticals (New 06/19/2018)

Company Contact Information:

Presentation Posting Date Related Information
Ortho Cyclen ® (norgestimate/ethinyl estradiol) 0.250 mg/0.035 mg; (NDC 50458-197-06)(NDC 50458-197-12)(NDC 50458-197-15)(NDC 50458-197-20) 06/19/2018 Due to commercial reasons, the Sponsor has decided to discontinue this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English